Abstract
The role of salivary epidermal growth factor(EGF) in the maintenance of ileal mucosal integrity wasstudied by evaluating the effects of sialoadenectomy onluminal EGF levels, ileal tissue resistance(Rt), and unidirectional flux of[51Cr]EDTA. Mice in groups 1 (SLX) and 2 (SLX+ EGF) were subjected to sialoadenectomy, while mice ingroups 3 (Sham) and 4 (Sham EGF) underwent a shamprocedure. All animals received normal diet and water, except that EGF(100 ng/ml) was added to water for SLX + EGF and Sham +EGF mice. At seven days after surgery, luminal EGFlevels in gastrointestinal segments and ileal R were significantly reduced by sialoadenectomy, whichwas prevented by EGF supplementation. Unidirectionalflux of [51Cr]EDTA was 6- to 22-fold greaterin the ileum of sialoadenectomized mice, which wasprevented by EGF administration. Results suggest thatsalivary EGF may be the major source of intestinal EGF,and it may play a role in maintenance of ileal mucosalintegrity.
Similar content being viewed by others
REFERENCES
Grisham MB, Granger DN: Neutrophil-mediated mucosal injury: role of reactive oxygen metabolites. Dig Dis Sci 33:6s-15s, 1988
Macdonald TT, Spencer J: Cell-mediated immune injury in the intestine. Gastroenterol Clin North Am 21:367-386, 1992
Mckay DM, Perdue MH: Intestinal Epithelial function: The case for immunophysiological regulation. Dig Dis Sci 38:1735-1745, 1993
Podolsky DK: Inflammatory bowel disease. N Engl J Med 325:928-937, 1991
Turnberg LA: Gastric mucosal defense mechanisms. Scand J Gastroenterol 20:37-40, 1985
Konturek JW, Brzozowski T, Konturek SJ: Epidermal growth factor in protection, repair, and healing of gastroduodenal mucosa. J Clin Gastroenterol 13:s88-s97, 1991
Cohen S: Isolation of mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Chem 237:1555-1562, 1962
Rao RK: Biologically active peptides in the gastrointestinal lumen. Life Sci 48:1685-1704, 1991
Olsen PS, Kirkegaard P, Poulsen SS, Nexo E: Adrenergic effect on exocrine secretion of rat submandibular epidermal growth factor. Gut 25:1234-1240, 1984
Rao RK: Luminal processing of epidermal growth factor in mouse gastrointestinal tract in vivo. Peptides 16:505-513, 1995
Sarosiek J, Bilski J, Murthy VLN, Slomiany S, Slomiany BL: Role of salivary epidermal growth factor in the maintenance of physicochemical characteristics of oral and gastric mucus coat. Biochem Biophys Res Commun 152:1421-1427, 1988
Olsen PS, Poulsen SS, Kirkegaard P, Nexo E: Role of submandibular saliva and epidermal growth factor in gastric cytoprotection. Gastroenterology 87:103-108, 1984
Carpenter G, Lembach KJ, Morrison MM, Cohen S: Characterization of the binding of 125I-labeled epidermal growth factor to human fibroblasts. J Biol Chem 250:4297-4304, 1975
Sheldon RJ, Malarchick ME, Fox DA, Burks TF, Porreca F: Pharmacological characterization of neural mechanisms regulating mucosal ion transport in mouse jejunum. J Pharmacol Exp Ther 249:572-582, 1989
Wallace JL, Macnaughton WK, Morris GP, Beck PL: Inhibition of leukotriene synthesis markedly accelerate healing in a rat model of inflammatory bowel disease. Gastroenterology 96:795-803, 1989
Bjarnason I, Peters TJ, Veal N: A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labeled EDTA absorption test. Lancet 2:323-325, 1983
Casellas F, Agaude S, Soriano F, Accarino A, Molero J, Guarner L: Intestinal permeability to 99mTc-diethylenetriam-minopentaacetic acid in inflammatory bowel disease. Am J Gastroenterol 81:767-770, 1986
Harris ML, Schiller HJ, Reilly PM, Donowitz M, Grisham MB, Buckley GB: Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence or epiphenomenon? Pharmacol Ther 53:375-408, 1992
Hollander D, Vadheim CM, Bretholz E, Delahunty T, Rotter JI: Increased intestinal permeability in patients with Crohn's disease and their relatives. Ann Intern Med 105:883-885, 1986
Hui WM, Chen BW, Kung AWC, Cho CH, Luk CT, Lam SK. Effect of epidermal growth factor on gastric blood flow in rats. Gastroenterology 104:1605-1610, 1993
Jenkins RT, Rooney PJ, Jones DB, Bienenstock J, Goodacre RI: Increased intestinal permeability in patients with rheumatoid arthritis: A side-effect of oral nonsteroidal anti-inflammatory drug therapy? Br J Rheumatol 26:103-107, 1987
Olaison G, Leandersson P, Sjodahl R, Tagesson C: Intestinal permeability to polyetheleneglycol 600 in Crohn's disease: Preoperative determination in a defined segment of the small intestine. Gut 29:196-199, 1988.
Williams JG, Hughes LE, Hallett MB: Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease. Gut 31:187-193, 1990
Joh T, Itoh M, Miyamoto T, Imai S, Ikeda T, Matsusako K, Katsumi K, Noguchi Y, Yakeuchi T, Kato T and Tanaka R. Epidermal growth factor in mouse digestive organs: Use of a sinsitive enzyme immunoassay. Gastroenterology 92:A1455, 1987
Kelly SM, Crampton J, Hunter JO: Salivary epidermal growth factor deficiency in rheumatoid disease: Influence of sicca syndrome. Gut 30:A1485, 1989
Kingsnorth AN, Smith P, Richards RC: Parotid salivary epidermal growth factor levels in human reflux oesophagitis and peptic ulcer disease. Gastroenterology 96:A257, 1989
Ohmura E, Emoto N, Tsushima T, Watanabe S, Takeiuchi T, Kawamura M, Shigemoto M, Shizume K: Salivary immunoreactive human epidermal growth factor in patients with peptic ulcer-disease. He pato-gastroenterology 34:160-163, 1987
Rao RK, Naon H, Mckilligan K, Sherman P, Thomas DW: Lower levels epidermal growth factor in saliva from patients with Crohn's disease and ulcerative colitis. Gastroenterology 106:A758, 1994
Li AKC, Schattenkerk ME, Huffman RG, Ross JS and Malt RA. Hypersecretion of submandibular saliva in male mice: Trophic response in small intestine. Gastroenterology 84:949-955, 1983
Freel RW, Hatch M, Earnest DI: Role of tight-junctional pathways in bile salt-induced increases in colonic permeability. Am J Physiol 245:G816-G823, 1983
Baker RD, Baker SS, Larosa K: Polarized Caco-2 cells: Effect of reactive oxygen metabolites on enterocyte barrier function. Dig Dis Sci 40:510-518, 1995
Velasquez OR, Henninger K, Fowler M, Tso P, Crissinger KD: Oleic acid-induced mucosal injury in developing piglet intestine. Am J Physiol 264:G576-G582, 1993
Rao RK, Porreca F: Epidermal growth factor inhibits Triton X-100-induced reduction in tissue resistance in mouse ileum in vitro. Eur J Pharmacol 104:209-212, 1996
Evangelista S, Maggi CA: Influence of sialoadenectomy on capsaicin-sensitive “gastric defense mechanism” in rats. Jpn J Pharmacol 56:377-380, 1991
Konturek SJ, Brozozowski T, Konturek PK, Majka J, Dembinski A: Role of salivary glands and epidermal growth factor (EGF) in gastric secretion and mucosal integrity in rats exposed to stress. Regul Pept 32:203-215, 1991
Tepperman BI, Soper BD: Interaction of nitric oxide and salivary gland epidermal growth factor in the modulation of rat gastric mucosal integrity. Br J Pharmacol 110:229-234, 1993
Scheving LA, Shiurba RA, Nguyen TD, Gray GM: Epidermal growth factor receptor of the intestinal enterocyte. Localization of lateral basal but not brush border membranes. J Biol Chem 264:1735-1741, 1989
Thompson JF, Vandenberg M, Stokkers PCF: Developmental regulation of epidermal growth factor receptor kinase in rat intestine. Gastroenterology 107:1278-1287, 1994
Rights and permissions
About this article
Cite this article
Rao, R.K., Thomas, D.W., Pepperl, S. et al. Salivary Epidermal Growth Factor Plays a Role in Protection of Ileal Mucosal Integrity. Dig Dis Sci 42, 2175–2181 (1997). https://doi.org/10.1023/A:1018855525989
Issue Date:
DOI: https://doi.org/10.1023/A:1018855525989